This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Cephalosporin Market Size, Trends & Analysis - Forecasts to 2028 By Type (Branded and Generic), By Application Type (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), By Route of Administration (Intravenous and Oral), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global cephalosporin market is expected to exhibit a CAGR of 3.6% from 2023 to 2028. Cephalosporins are a type of antibiotics derived from a fungus used in treating bacterial infections by interrupting bacterial cell wall formation, causing their death. They are categorized into generations based on their bacterial activity spectrum. They are often prescribed for a range of respiratory, skin, and urinary tract infections and more severe cases. Proper use under medical guidance is crucial to maintain their effectiveness and prevent antibiotic resistance.
The global cephalosporin market is growing due to several reasons. The increasing global occurrence of infectious diseases, particularly bacterial infections, is on the rise due to multiple factors such as population expansion, urbanization, travel, and alterations in bacteria’s resistance. As bacteria adapt and become more resistant to current antibiotics, there is a growing necessity for advanced antibiotics like cephalosporins to effectively address these infections. In surgical procedures, whether elective or essential, antibiotics are often administered to prevent infections post-surgery. Cephalosporins are frequently chosen for their broad effectiveness against various bacteria, lowering the possibility of infections and complications at surgical sites. Significant investments by pharmaceutical firms in research and development are dedicated to innovating new formulations of cephalosporins. These endeavours are focused on enhancing drug performance, minimizing side effects, and widening the range of bacteria targeted, aligning with the changing requirements of both healthcare providers and patients.
Various restraints hinder the growth of the market. The process for regulatory approval of new antibiotics, including cephalosporins, involves rigorous clinical trials and stringent safety and efficacy evaluations. These extensive requirements often result in lengthy approval timelines and high development costs, delaying the introduction of new drugs to the market and creating barriers for smaller pharmaceutical companies with limited resources. Once patents for original cephalosporin drugs expire, generic versions enter the market, leading to price competition and decreased market share for the original drug manufacturers. This price erosion affects profit margins and revenue for the original drug companies.
Based on the type, the market is segmented into branded and generic. The branded segment is expected to be the largest segment during the forecast period. Brand recognition and loyalty drive consumer trust in established pharmaceutical companies, leading to higher sales of branded cephalosporins. Additionally, branded medications often undergo extensive research, offering innovative formulations, improved efficacy, and perceived higher quality, commanding premium pricing. Healthcare providers prefer trusted brands, contributing to a larger market share for branded cephalosporins despite competition from generics, which enter the market after patent expirations, maintaining the branded segment's substantial market presence.
The generic segment is expected to be the fastest-growing segment in the global cephalosporin market during the forecast period. This is due to increasing patent expirations of original drugs, allowing the entry of generic versions. This entry fosters increased competition, driving down prices and expanding patient access to more affordable alternatives. Generic manufacturers face lower development costs and can swiftly introduce their versions post-patent expiration, attracting a larger market share. Additionally, healthcare systems often favour cost-effective generics, propelling their rapid growth within the cephalosporin market.
Based on route of administration, the market is segmented into intravenous and oral. The intravenous segment is expected to be the largest segment during the forecast period. IV formulations offer rapid and efficient delivery of antibiotics, which is crucial in severe infections where immediate action is necessary. Hospitals and healthcare facilities commonly use IV cephalosporins for serious bacterial infections, surgical prophylaxis, and critical cases requiring precise dosing. Additionally, IV administration ensures higher bioavailability and allows for better control over dosage, making it the preferred route for healthcare professionals in managing severe infections, contributing to its substantial market share.
The oral segment is expected to be the fastest-growing segment in the global cephalosporin market. Oral cephalosporins offer patient-friendly options, allowing for self-administration outside healthcare settings, promoting compliance, and reducing hospitalization. Additionally, advancements in oral formulation technology enhance bioavailability and stability, expanding the range of treatable infections. With increasing preference for outpatient care and the convenience of oral dosing, this segment sees accelerated growth, catering to patient preferences for accessible and effective treatment options.
On the basis of application type, the market is segmented into respiratory tract infection, skin infection, ear infection, urinary tract infection, sexually transmitted infection, and others. The respiratory tract infection (RTIs) segment is expected to be the largest segment during the forecast period. RTIs encompass a broad spectrum of illnesses, including pneumonia, bronchitis, and sinusitis, among others. Cephalosporins exhibit potent activity against the bacteria commonly responsible for these infections. Given the frequent occurrence and severity of respiratory infections worldwide, the consistent demand for cephalosporins for treating RTIs contributes significantly to this segment's dominance in the market.
The skin infection segment is expected to be the fastest-growing segment in the global cephalosporin market during the forecast period. Cephalosporins effectively target a broad spectrum of bacteria commonly associated with skin infections. Additionally, the rising incidence of antibiotic-resistant strains demands more potent antibiotics like cephalosporins. As skin infections are frequently encountered and require timely and effective treatment, the demand for cephalosporins in this segment accelerates, contributing to its status as the fastest-growing segment within the market.
North America is analysed to account for the largest share in the global cephalosporin market during the forecast period. The region boasts a well-established healthcare infrastructure, extensive research and development capabilities, and a high prevalence of infectious diseases. Additionally, robust funding for healthcare and a proactive approach toward combating antibiotic resistance contribute to the dominance. Strong collaborations between pharmaceutical companies and academic institutions foster innovation, driving the development and adoption of cephalosporins, thereby solidifying North America's leading position in this market.
Asia Pacific is expected to be the fastest-growing region across the global cephalosporin market. Rapid population growth, increasing urbanization, and expanding healthcare infrastructure across countries in this region drive the heightened demand for antibiotics like cephalosporins. Moreover, a surge in infectious diseases and a rise in surgical procedures further amplify the need for effective antibacterial treatments. Additionally, improving economic conditions and growing awareness of healthcare among the populace contribute to the significant market expansion of cephalosporin market in the APAC region.
Key players operating in the global cephalosporin market Include Pfizer Inc., Sanofi, Glaxosmithkline, Merck & Co., Novartis AG, Lupin Pharmaceuticals, Bristol-Myers Squibb Company, Abbvie Inc., Teva Pharmaceutical, and F. Hoffmann-La Roche Ltd., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In May 2023, Novartis planned to convert Sandoz into a standalone company primarily focusing on anti-infectives. By then, Sandoz had invested over 250 million euros in antibiotic manufacturing, acquired biosimilars, and developed respiratory medicine delivery devices. These investments and developments were part of Sandoz's strategies and initiatives before the conversion into a standalone entity within Novartis.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL CEPHALOSPORIN MARKET, BY ROUTE OF ADMINISTRATION
4.1 Introduction
4.2 Cephalosporin Market: Route of Administration Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Intravenous
4.4.1 Intravenous Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Oral
4.5.1 Oral Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL CEPHALOSPORIN MARKET, BY TYPE
5.1 Introduction
5.2 Cephalosporin Market: Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Branded
5.4.1 Branded Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Generic
5.5.1 Generic Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL CEPHALOSPORIN MARKET, BY APPLICATION TYPE
6.1 Introduction
6.2 Cephalosporin Market: Application Type Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Respiratory Tract Infection
6.4.1 Respiratory Tract Infection Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5 Skin Infection
6.5.1 Skin Infection Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6 Ear Infection
6.6.1 Ear Infection Market Estimates and Forecast, 2020-2028 (USD Billion)
6.7 Urinary Tract Infection
6.7.1 Urinary Tract Infection Market Estimates and Forecast, 2020-2028 (USD Billion)
6.8 Sexually Transmitted Infection
6.8.1 Sexually Transmitted Infection Market Estimates and Forecast, 2020-2028 (USD Billion)
6.9 Other Applications
6.9.1 Other Applications Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL CEPHALOSPORIN MARKET, BY REGION
7.1 Introduction
7.2 North America Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.1 By Route of Administration
7.2.2 By Type
7.2.3 By Application Type
7.2.4 By Country
7.2.4.1 U.S. Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.1.1 By Route of Administration
7.2.4.1.2 By Type
7.2.4.1.3 By Application Type
7.2.4.2 Canada Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.2.1 By Route of Administration
7.2.4.2.2 By Type
7.2.4.2.3 By Application Type
7.2.4.3 Mexico Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.3.1 By Route of Administration
7.2.4.3.2 By Type
7.2.4.3.3 By Application Type
7.3 Europe Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.1 By Route of Administration
7.3.2 By Type
7.3.3 By Application Type
7.3.4 By Country
7.3.4.1 Germany Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.1.1 By Route of Administration
7.3.4.1.2 By Type
7.3.4.1.3 By Application Type
7.3.4.2 U.K. Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.2.1 By Route of Administration
7.3.4.2.2 By Type
7.3.4.2.3 By Application Type
7.3.4.3 France Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.3.1 By Route of Administration
7.3.4.3.2 By Type
7.3.4.3.3 By Application Type
7.3.4.4 Italy Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.4.1 By Route of Administration
7.3.4.4.2 By Type
7.2.4.4.3 By Application Type
7.3.4.5 Spain Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.5.1 By Route of Administration
7.3.4.5.2 By Type
7.2.4.5.3 By Application Type
7.3.4.6 Netherlands Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.7.1 By Route of Administration
7.3.4.7.2 By Type
7.2.4.7.3 By Application Type
7.3.4.7 Rest of Europe Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.7.1 By Route of Administration
7.3.4.7.2 By Type
7.2.4.7.3 By Application Type
7.4 Asia Pacific Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.1 By Route of Administration
7.4.2 By Type
7.4.3 By Application Type
7.4.4 By Country
7.4.4.1 China Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.1.1 By Route of Administration
7.4.4.1.2 By Type
7.4.4.1.3 By Application Type
7.4.4.2 Japan Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.2.1 By Route of Administration
7.4.4.2.2 By Type
7.4.4.2.3 By Application Type
7.4.4.3 India Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.3.1 By Route of Administration
7.4.4.3.2 By Type
7.4.4.3.3 By Application Type
7.4.4.4 South Korea Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.4.1 By Route of Administration
7.4.4.4.2 By Type
7.4.4.4.3 By Application Type
7.4.4.5 Singapore Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.5.1 By Route of Administration
7.4.4.5.2 By Type
7.4.4.5.3 By Application Type
7.4.4.6 Malaysia Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.7.1 By Route of Administration
7.4.4.7.2 By Type
7.4.4.7.3 By Application Type
7.4.4.7 Thailand Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.7.1 By Route of Administration
7.4.4.7.2 By Type
7.4.4.7.3 By Application Type
7.4.4.8 Indonesia Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.8.1 By Route of Administration
7.4.4.8.2 By Type
7.4.4.8.3 By Application Type
7.4.4.9 Vietnam Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.9.1 By Route of Administration
7.4.4.9.2 By Type
7.4.4.9.3 By Application Type
7.4.4.10 Taiwan Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.10.1 By Route of Administration
7.4.4.10.2 By Type
7.4.4.10.3 By Application Type
7.4.4.11 Rest of Asia Pacific Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.11.1 By Route of Administration
7.4.4.11.2 By Type
7.4.4.11.3 By Application Type
7.5 Middle East and Africa Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.1 By Route of Administration
7.5.2 By Type
7.5.3 By Application Type
7.5.4 By Country
7.5.4.1 Saudi Arabia Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.1.1 By Route of Administration
7.5.4.1.2 By Type
7.5.4.1.3 By Application Type
7.5.4.2 U.A.E. Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.2.1 By Route of Administration
7.5.4.2.2 By Type
7.5.4.2.3 By Application Type
7.5.4.3 Israel Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.3.1 By Route of Administration
7.5.4.3.2 By Type
7.5.4.3.3 By Application Type
7.5.4.4 South Africa Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.4.1 By Route of Administration
7.5.4.4.2 By Type
7.5.4.4.3 By Application Type
7.5.4.5 Rest of Middle East and Africa Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.5.1 By Route of Administration
7.5.4.5.2 By Type
7.5.4.5.2 By Application Type
7.6 Central and South America Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.1 By Route of Administration
7.7.2 By Type
7.7.3 By Application Type
7.7.4 By Country
7.7.4.1 Brazil Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.1.1 By Route of Administration
7.7.4.1.2 By Type
7.7.4.1.3 By Application Type
7.7.4.2 Argentina Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.2.1 By Route of Administration
7.7.4.2.2 By Type
7.7.4.2.3 By Application Type
7.7.4.3 Chile Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.3.1 By Route of Administration
7.7.4.3.2 By Type
7.7.4.3.3 By Application Type
7.7.4.4 Rest of Central and South America Cephalosporin Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.4.1 By Route of Administration
7.7.4.4.2 By Type
7.7.4.4.3 By Application Type
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 Pfizer Inc.
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Sanofi
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Lupin Pharmaceuticals
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 F. Hoffmann-La Roche
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 GlaxoSmithKline
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 AbbVie Inc.
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.7 Novartis AG
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Merck & Co.
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Teva Pharmaceuticals
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Bristol Myers Squibb Company
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
2 Intravenous Market, By Region, 2020-2028 (USD Billion)
3 Oral Market, By Region, 2020-2028 (USD Billion)
4 Global Cephalosporin Market, By Type, 2020-2028 (USD Billion)
5 Branded Market, By Region, 2020-2028 (USD Billion)
6 Generic Market, By Region, 2020-2028 (USD Billion)
7 Global Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
8 Respiratory Tract Infection Market, By Region, 2020-2028 (USD Billion)
9 Skin Infection Market, By Region, 2020-2028 (USD Billion)
10 Ear Infection Market, By Region, 2020-2028 (USD Billion)
11 Urinary Tract Infection Market, By Region, 2020-2028 (USD Billion)
12 Sexually Transmitted Infection Market, By Region, 2020-2028 (USD Billion)
13 Other Applications Market, By Region, 2020-2028 (USD Billion)
14 Regional Analysis, 2020-2028 (USD Billion)
15 North America Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
16 North America Cephalosporin Market, By Type, 2020-2028 (USD Billion)
17 North America Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
18 North America Cephalosporin Market, By Country, 2020-2028 (USD Billion)
19 U.S. Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
20 U.S. Cephalosporin Market, By Type, 2020-2028 (USD Billion)
21 U.S. Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
22 Canada Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
23 Canada Cephalosporin Market, By Type, 2020-2028 (USD Billion)
24 Canada Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
25 Mexico Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
26 Mexico Cephalosporin Market, By Type, 2020-2028 (USD Billion)
27 Mexico Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
28 Europe Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
29 Europe Cephalosporin Market, By Type, 2020-2028 (USD Billion)
30 Europe Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
31 Europe Cephalosporin Market, By COUNTRY, 2020-2028 (USD Billion)
32 Germany Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
33 Germany Cephalosporin Market, By Type, 2020-2028 (USD Billion)
34 Germany Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
35 U.K. Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
36 U.K. Cephalosporin Market, By Type, 2020-2028 (USD Billion)
37 U.K. Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
38 France Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
39 France Cephalosporin Market, By Type, 2020-2028 (USD Billion)
40 France Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
41 Italy Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
42 Italy Cephalosporin Market, By Type, 2020-2028 (USD Billion)
43 Italy Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
44 Spain Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
45 Spain Cephalosporin Market, By Type, 2020-2028 (USD Billion)
46 Spain Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
47 Netherlands Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
48 Netherlands Cephalosporin Market, By Type, 2020-2028 (USD Billion)
49 Netherlands Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
50 Rest Of Europe Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
51 Rest Of Europe Cephalosporin Market, By Type, 2020-2028 (USD Billion)
52 Rest of Europe Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
53 Asia Pacific Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
54 Asia Pacific Cephalosporin Market, By Type, 2020-2028 (USD Billion)
55 Asia Pacific Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
56 Asia Pacific Cephalosporin Market, By Country, 2020-2028 (USD Billion)
57 China Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
58 China Cephalosporin Market, By Type, 2020-2028 (USD Billion)
59 China Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
60 India Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
61 India Cephalosporin Market, By Type, 2020-2028 (USD Billion)
62 India Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
63 Japan Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
64 Japan Cephalosporin Market, By Type, 2020-2028 (USD Billion)
65 Japan Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
66 South Korea Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
67 South Korea Cephalosporin Market, By Type, 2020-2028 (USD Billion)
68 South Korea Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
69 Thailand Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
70 Thailand Cephalosporin Market, By Type, 2020-2028 (USD Billion)
71 Thailand Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
72 Indonesia Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
73 Indonesia Cephalosporin Market, By Type, 2020-2028 (USD Billion)
74 Indonesia Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
75 Australia Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
76 Australia Cephalosporin Market, By Type, 2020-2028 (USD Billion)
77 Australia Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
78 Vietnam Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
79 Vietnam Cephalosporin Market, By Type, 2020-2028 (USD Billion)
80 Vietnam Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
81 Malaysia Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
82 Malaysia Cephalosporin Market, By Type, 2020-2028 (USD Billion)
83 Malaysia Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
84 Singapore Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
85 Singapore Cephalosporin Market, By Type, 2020-2028 (USD Billion)
86 Singapore Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
87 Philippines Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
88 Philippines Cephalosporin Market, By Type, 2020-2028 (USD Billion)
89 Philippines Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
90 Rest Of Asia pacific Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
91 Rest Of Asia Pacific Cephalosporin Market, By Type, 2020-2028 (USD Billion)
92 Rest of Asia pacific Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
93 Middle East and Africa Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
94 Middle East and Africa Cephalosporin Market, By Type, 2020-2028 (USD Billion)
95 Middle East and Africa Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
96 Middle East and Africa Cephalosporin Market, By Country, 2020-2028 (USD Billion)
97 Saudi Arabia Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
98 Saudi Arabia Cephalosporin Market, By Type, 2020-2028 (USD Billion)
99 Saudi Arabia Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
100 UAE Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
101 UAE Cephalosporin Market, By Type, 2020-2028 (USD Billion)
102 UAE Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
103 Israel Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
104 Israel Cephalosporin Market, By Type, 2020-2028 (USD Billion)
105 Israel Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
106 South Africa Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
107 South Africa Cephalosporin Market, By Type, 2020-2028 (USD Billion)
108 South Africa Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
109 Rest Of Middle East and Africa Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
110 Rest Of Middle East and Africa Cephalosporin Market, By Type, 2020-2028 (USD Billion)
111 Rest of Middle East and Africa Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
112 Central and South America Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
113 Central and South America Cephalosporin Market, By Type, 2020-2028 (USD Billion)
114 Central and South America Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
115 Central and South America Cephalosporin Market, By Country, 2020-2028 (USD Billion)
116 Brazil Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
117 Brazil Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
118 Brazil Cephalosporin Market, By Type, 2020-2028 (USD Billion)
119 Argentina Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
120 Argentina Cephalosporin Market, By Type, 2020-2028 (USD Billion)
121 Argentina Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
122 Chile Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
123 Chile Cephalosporin Market, By Type, 2020-2028 (USD Billion)
124 Chile Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
125 Rest Of Central and South America Cephalosporin Market, By Route of Administration, 2020-2028 (USD Billion)
126 Rest Of Central and South America Cephalosporin Market, By Type, 2020-2028 (USD Billion)
127 Rest of Central and South America Cephalosporin Market, By Application Type, 2020-2028 (USD Billion)
128 Pfizer Inc.: Products & Services Offering
129 Sanofi: Products & Services Offering
130 Lupin Pharmaceuticals: Products & Services Offering
131 F. HOFFMANN-LA ROCHE: Products & Services Offering
132 GlaxoSmithKline: Products & Services Offering
133 AbbVie Inc.: Products & Services Offering
134 NOVARTIS AG: Products & Services Offering
135 Merck & Co.: Products & Services Offering
136 TEVA PHARMACEUTICALS: Products & Services Offering
137 Bristol Myers Squibb Company: Products & Services Offering
138 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Cephalosporin Market Overview
2 Global Cephalosporin Market Value From 2020-2028 (USD Billion)
3 Global Cephalosporin Market Share, By Route of Administration (2022)
4 Global Cephalosporin Market Share, By Type (2022)
5 Global Cephalosporin Market Share, By Application Type (2022)
6 Global Cephalosporin Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Cephalosporin Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Cephalosporin Market
11 Impact Of Challenges On The Global Cephalosporin Market
12 Porter’s Five Forces Analysis
13 Global Cephalosporin Market: By Route of Administration Scope Key Takeaways
14 Global Cephalosporin Market, By Route of Administration Segment: Revenue Growth Analysis
15 Intravenous Market, By Region, 2020-2028 (USD Billion)
16 Oral Market, By Region, 2020-2028 (USD Billion)
17 Global Cephalosporin Market: By Type Scope Key Takeaways
18 Global Cephalosporin Market, By Type Segment: Revenue Growth Analysis
19 Branded Market, By Region, 2020-2028 (USD Billion)
20 Generic Market, By Region, 2020-2028 (USD Billion)
21 Global Cephalosporin Market: By Application Type Scope Key Takeaways
22 Global Cephalosporin Market, By Application Type Segment: Revenue Growth Analysis
23 Respiratory Tract Infection Market, By Region, 2020-2028 (USD Billion)
24 Skin Infection Market, By Region, 2020-2028 (USD Billion)
25 Ear Infection Market, By Region, 2020-2028 (USD Billion)
26 Urinary Tract Infection Market, By Region, 2020-2028 (USD Billion)
27 Sexually Transmitted Infection Market, By Region, 2020-2028 (USD Billion)
28 Other Applications Market, By Region, 2020-2028 (USD Billion)
29 Regional Segment: Revenue Growth Analysis
30 Global Cephalosporin Market: Regional Analysis
31 North America Cephalosporin Market Overview
32 North America Cephalosporin Market, By Route of Administration
33 North America Cephalosporin Market, By Type
34 North America Cephalosporin Market, By Application Type
35 North America Cephalosporin Market, By Country
36 U.S. Cephalosporin Market, By Route of Administration
37 U.S. Cephalosporin Market, By Type
38 U.S. Cephalosporin Market, By Application Type
39 Canada Cephalosporin Market, By Route of Administration
40 Canada Cephalosporin Market, By Type
41 Canada Cephalosporin Market, By Application Type
42 Mexico Cephalosporin Market, By Route of Administration
43 Mexico Cephalosporin Market, By Type
44 Mexico Cephalosporin Market, By Application Type
45 Four Quadrant Positioning Matrix
46 Company Market Share Analysis
47 Pfizer Inc.: Company Snapshot
48 Pfizer Inc.: SWOT Analysis
49 Pfizer Inc.: Geographic Presence
50 Sanofi: Company Snapshot
51 Sanofi: SWOT Analysis
52 Sanofi: Geographic Presence
53 Lupin Pharmaceuticals: Company Snapshot
54 Lupin Pharmaceuticals: SWOT Analysis
55 Lupin Pharmaceuticals: Geographic Presence
56 F. Hoffmann-La Roche: Company Snapshot
57 F. Hoffmann-La Roche: SWOT Analysis
58 F. Hoffmann-La Roche: Geographic Presence
59 Glaxosmithkline: Company Snapshot
60 Glaxosmithkline: SWOT Analysis
61 Glaxosmithkline: Geographic Presence
62 Abbvie Inc.: Company Snapshot
63 Abbvie Inc.: SWOT Analysis
64 Abbvie Inc.: Geographic Presence
65 Novartis AG : Company Snapshot
66 Novartis AG : SWOT Analysis
67 Novartis AG : Geographic Presence
68 Merck & Co.: Company Snapshot
69 Merck & Co.: SWOT Analysis
70 Merck & Co.: Geographic Presence
71 Teva Pharmaceuticals: Company Snapshot
72 Teva Pharmaceuticals: SWOT Analysis
73 Teva Pharmaceuticals: Geographic Presence
74 Bristol Myers Squibb Company: Company Snapshot
75 Bristol Myers Squibb Company: SWOT Analysis
76 Bristol Myers Squibb Company: Geographic Presence
77 Other Companies: Company Snapshot
78 Other Companies: SWOT Analysis
79 Other Companies: Geographic Presence
The Global Cephalosporin Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cephalosporin Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
